ClinicalTrials.govpublic full text
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
leukemia, acute lymphoblastic leukemia, lymphoma, hyper-cvad, all, remission duration, chemotherapy, asparaginase, cyclophosphamide, cytarabine, dexamethasone, doxorubicin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 856326
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.